Clinical Trial Update: Inactivated Convalescent Plasma as a Therapeutic Alternative in Patients CoViD-19 [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating inactivated convalescent plasma as a therapeutic alternative for patients with coronavirus infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronavirus Infection

Drugs mentioned

• Inactivated convalescent plasma (inactivated convalescent plasma)

Snippet

Sponsor: National Blood Center Foundation, Hemolife | Conditions: Infections, Coronavirus | Phase 2 | Status: UNKNOWN